People News: Alexion Pharmaceuticals and KV Pharmaceutical
Specialty firm KV Pharmaceutical named David Van Vliet CEO, with a term through December 31, 2011. Van Vliet has served as interim president and CEO since December 2008.
Novocure and Glue Advertising put on a Facebook Live event promoting the cancer treatment Optune in March.
Warc anticipates global adspend growth this year to ring in at a healthy 4.7%, or $572bn (£410bn).
Brands should refrain from tweets that are over 100 characters, according to Twitter's director of brand strategy.